Wednesday, 10 December 2025
Histone deacetylase inhibitor gel shows promise for the treatment of patients with basal cell carcinoma

Added: 08.11.2021 20:48 | 225 views | 0 comments

Source: www.cell.com
Source: www.cell.com

Remetinostat, a topical cream and first-in-class inhibitor of histone deacetylation, showed signs of clinical efficacy in patients with basal cell carcinoma.

More in www.sciencedaily.com »



Image with code
CommentsComments:
Tags

Africa

 

Australia

 

Bacteria

 

Brandy

 

Brexit

 

California

 

Canada

 

Cancer

 

Children

 

Congress

 

DARPA

 

Depression

 

Donald Trump

 

Economy

 

Election

 

England

 

Facebook

 

Fire

 

France

 

Gamers

 

Genes

 

Girls

 

Gold

 

Government

 

Honda

 

Hotels

 

India

 

Ireland

 

Kids

 

London

 

Mexico

 

Money

 

Music

 

New York

 

Oscars

 

Planes

 

Police

 

President

 

Russia

 

Scientists

 

Sleep

 

SPA

 

Targus

 

Technology

 

Teeth

 

Uber

 

United States

 

Washington

 

White House

 

Women

 
advertising


Copyright © 2008 - 2025 All Terra News - breaking news and headlines from around the world  - all rights reserved